InvestorsHub Logo
Followers 33
Posts 2666
Boards Moderated 0
Alias Born 10/28/2013

Re: stocking4ms post# 1016

Sunday, 12/06/2015 10:35:34 PM

Sunday, December 06, 2015 10:35:34 PM

Post# of 1397
The data from August, reprinted in the recent SA article, page 3...

http://seekingalpha.com/article/3642996-mei-pharma-should-be-bought-ahead-of-ash-conference

That data just points to a buyout possibility, in my opionion. Just stare at that data for a while and I think you might agree.

Nothing I have heard... but since it really looks that way to me, and I bought in because of it, I don't mind putting the idea in other people's minds.

I worry a little too. I do understand that people, including JBEM, felt a little burned by the last data release. I suppose there could be a negative surprise, but not sure how. Median OS has to be pretty good at this point if that SA Article was accurate. My only concern is whether they can update the CR number in a bad way. I wouldn't think they could change it after trial end date... but maybe if they are still having to watch for the median OS... maybe they also update CR? I don't think so, but a small concern. Of course CR could go up.

There can always be tricks with the stock itself... but so far nothing. I don't consider the recent employee benefit / dilution a big deal. I hope it is them patting themselves on the back for a job well done, and possibly, positioning themselves for aquisition... or partnering for phase 3 with associated SP rise and liquidity.

But I have no inside info, nor anything beyond the recent PR's and reports.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MEIP News